Page 942 - Textbook of Pathology, 6th Edition

926 Mycotoxin, 219, 222, 634 Myositis ossificans, 869-70 mercuric chloride, 680
MYC gene, 211t, 212 Myxoedema, 803-04 myeloma, 382, 684
Myelin figures, 31f Myxoma heart, 459 reflux, 682
Myeloblast, 345 Myxoma, odontogenic, 532 Nephrosclerosis, 687-89
Myeloblast versus lymphoblast, 347t Myxomatosis, 226 benign, 687-88
Myelocele, 873 Myxomatous degeneration of cardiac valves, malignant, 688-89
Myelocyte, 345 451-52 Nephrotic syndrome, 99, 660
Myelodysplastic syndrome (MDS), 361-62 versus nephritic syndrome, 662t
FAB classification of, 361 Nerve sheath tumours, 893-95
WHO classification, 361 N Nervous system, 871-95
Myelofibrosis, 325-26 central, 871-91
Chronic idiopathic, 360-61 Naevi, naevocellular, 41f, 787 healing of, 172, 891-92
Myelogram, 287t Naevus sebaceus, 785 normal structure of, 871-72
Myeloid metaplasia, 360-61 Nail-patella syndrome, 678 peripheral, 891-95
Myeloid neoplasms, 356-65, 357t Nasopharyngeal carcinoma, anaplastic, 225-26, Neurilemmoma, 893
acute myeloid leukamia, 362-64 518-19 versus neurofibroma, 895t
chronic idiopathic myelofibrosis, 360-61 Natural killer (NK) cells, 64, 230, 368, 380 Neuroblastoma, 517, 800-01, 886t
chronic myeloid leukaemia, 357-59 Neck, 520-21 Neuroendocrine system, 791-829
essential thrombocytosis, 360 cysts of, 520-21 Neurofibrillary tangles, 884
myelodysplastic syndromes, 361-62 tumours in, 521 Neurofibroma, 893-94
polycythaemia vera, 359 Necrosis, 44-46 plexiform, 894
Myeloid series, 345-46 avascular, bone, 833-34 versus schwannoma, 895t
Myelolipoma, 800 bridging, 611-12 Neurofibromatosis, 206, 893
Myeloma, 380-84 caseous, 45, 155 Neurofibrosarcoma, 894-95
kidney, 382, 684 centrilobular, haemorrhagic, 106 Neurofilaments, 16, 23-24
multiple, 380-84 coagulative, 45 Neuroglia, 871-72
neuropathy, 382 colliquative, 45 Neurohypophysis, 793
Myeloma cells, 382f cortical, renal, 690 Neuronophagia, 872
Myeloproliferative disorders, 357-61 fat, 45-46 Neuroma, acoustic, 515, 893
Myoblastoma, granular cell, 525, 869 fibrinoid, 46 traumatic, 893
Myocardial blood supply, 418 liquefactive, 45 Neuromuscular diseases, 857-59
Myocardial depressant factor (MDF), 112 liver cells, 604-05 Neuropathy, peripheral, 892-93, 826
Myocardial infarction, 429-38 massive, 613-14 Neuropeptide, 137
changes in early, 434 piecemeal, 611 Neuropil, 871
chemical and histochemical, 434 submassive, 613-14 Neurosyphilis, 163
changes in, 431-34 types of, 45-46 Neutropenia, 141, 348
clinical features of, 434-35 versus apoptosis, 48t Neutrophil alkaline phosphatase (NAP), 353,
complications of, 435-36 Necrotising enterocolitis, 181, 565 358
CK in, 434 Necrotising papillitis, 678, 682 Neutrophilia, 141, 348
diagnosis of, 434-35 Negri bodies, 186 Neutrophils, 64, 141, 347-49
ECG changes in, 434 Neonatal hepatitis, 601-02 toxic granules in, 349f
electron microscopic changes in, 434 Neoplasia, (also see under Tumours), 192-235 vacuoles in, 349f
enzyme determination in, 434-35 characteristics of, 194-205 Nexus, 25
etiopathogenesis of, 429-30 classification of, 193t Niacin, 253
INDEX
gross changes in, 431-33 clinical aspects of, 228-35 Niemann-Pick disease, 262-63
incidence of, 429 definition of, 192 Nissl substance, 871
LDH in, 434-35 diagnosis of, 232-35 Nitric oxide mechanism, 139
location of, 430-31 epidemiology of, 205-08 Nitrosamines, 219, 555
myoglobin in, 435 etiology of, 208-28 NK cells, 64, 230, 368, 380
morphologic features of, 431-33 intraepithelial, 207 Nodular fascitis, 862
serum cardiac markers in, 434-35 pathogenesis of, 208-28 Nodule, vocal, 519
transmural versus subendocardial, 430t Neoplastic cells, 196-99 Noma, 523
troponins in, 435 Neovascularisation, 167, 199, 215 Non-Hodgkin’s lymphomas (NHL), 373-380
types of, 430 Nephritic syndrome, 99, 660 adult T cell (ATLL), 379-80
Myocardial ischaemia, non-infarct effects of, versus nephrotic syndrome, 662t anaplastic large cell (ALCL), 380
429f Nephritic versus nephrotic oedema, 99t, 662t Burkitt type, 377-78
Myocarditis, 452-54 Nephritis, hereditary, 678 CD markers in, 367f
classification of, 452t Nephritis, tubulointerstitial, 680-85 classification of, 365-68
Fiedler’s, 453 Nephroblastoma, 696-98 etiology of, 354-55
granulomatous, 453 Nephrocalcinosis, 53f, 684-85, 816 pathogenesis of, 355-56
idiopathic, 453 Nephrolithiasis, 690-92 extranodal, 378
in connective tissue diseases, 453 Nephroma, mesoblastic, 694 follicular, 377
infective, 453 Nephron, structure of, 649-52 maltoma, 378
miscellaneous types of, 453-54 Nephronophthiasis-medullary marginal zone, 378
rheumatic, 441-42 cystic kidney disease mycosis fungoides, 379-80
Myofibroblast, 167, 396 complex, 659 mantle cell, 378
Myoglobin, 435 Nephropathy, mature B cell type, 374-79
Myometritis, 732 analgesic (phenacetin abuse), 681t mature T cell type, 379-80
Myometrium, 730-38 diabetic, 677-78 monocytoid, 379
normal structure of, 730 IgA, 674 periperal B cell type, 374-79
Myopathies, 858-59 lupus, 675-76 peripheral T cell type, 379-80